SmithSolve provides a full range of corporate communications, public relations, and patient advocacy services to biopharmaceutical companies of all sizes. From integrated communication plans to targeted campaigns, we tailor our work to achieve your goals.
-
Corporate Communications
Your brand is more than a logo – it’s everything your company says and does. We help you build confidence through clear, consistent communication that is easily understood and shared. We support companies from startup through established, global leaders.
- Corporate Branding
- Employee Engagement
- Investor Relations
- Issues Management
- Media Relations
-
Patient Engagement & Advocacy
The perspectives of people living with rare diseases are critical to successful drug development. Patient organizations play a major role in connecting, educating, empowering, and supporting patient communities. These groups also drive new research, advocate for policy, and contribute valuable insight to regulatory authorities. We build sustainable, mutually beneficial relationships with these patients and advocates, providing your company with actionable insights into their needs and goals.
- Advocacy Landscape Analysis
- Advocacy Relations
- Patient Advisory Boards
- Patient Stories
-
Product & Pipeline Communications
We support investigational therapies and marketed therapies throughout their lifecycles. We translate complex science with clarity and accuracy to help all stakeholders understand your company and product strategy, performance, and value.
- Clinical Trial Recruitment
- Data Announcements
- Product Launches
- Value and Access Messages/Approach
-
Digital & Social Strategy
Smart digital strategy and high impact design can maximize the value and reach of your message. We listen to the social media conversation and define your voice.
- Search Optimization and Marketing
- Social Conversation Mapping
- Social Media Engagement
- Website Development
What sets SmithSolve apart is the level of strategic thinking …
Paul G. Chaney
President and CEO
Panoptica, Inc.
